RESMED INC — Director's Dealing 2019

Nov 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-01

Reporting Person: WAREHAM JOHN P (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-01	ResMed Common Stock	M	9536	$58.24	Acquired	21936	Direct
2019-11-01	ResMed Common Stock	S	9536	$148.147	Disposed	12400	Direct
2019-11-04	ResMed Common Stock	M	5000	$58.24	Acquired	17400	Direct
2019-11-04	ResMed Common Stock	S	5000	$147.75	Disposed	12400	Direct
2019-11-04	ResMed Common Stock	M	5956	$58.24	Acquired	18356	Direct
2019-11-04	ResMed Common Stock	S	5956	$148.00	Disposed	12400	Direct
2019-11-04	ResMed Common Stock	G	1100	—	Disposed	11300	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-01	ResMed Common Stock Options	$58.24	M	9536	Disposed	2022-11-19	ResMed Commmon Stock (9536)	Direct
2019-11-04	ResMed Common Stock Options	$58.24	M	5000	Disposed	2022-11-19	ResMed Commmon Stock (5000)	Direct
2019-11-04	ResMed Common Stock Options	$58.24	M	5956	Disposed	2022-11-19	ResMed Commmon Stock (5956)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $148.00 to $148.52. The price reported above reflects the weighted average sale price.

F2: Gift of shares to Washington University in St. Louis. Mr. Wareham has no beneficial interest, control or dispositive power over the gifted shares.